Kiromic Biopharma appoints Brian Hungerford as CFO with $375K salary, 21,900 RSUs

Kiromic Biopharma, Inc.

Brian Hungerford named CFO effective October 1, 2023; reports to CEO.
Base salary of $375,000 per year; eligible for annual target bonus of 40% of base salary.
Granted 21,900 restricted shares vesting on October 1, 2024.
Severance: 12 months base salary plus bonus/benefits if terminated without cause or for good reason.
Unvested equity accelerates 24 months post-termination under certain severance conditions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian Hungerford

Chief Financial Officer

Kiromic Biopharma, Inc.

Effective: 2023-10-01
Filed: October 3, 2023, 7:59 PM ET

On October 1, 2023, Kiromic Biopharma, Inc. (the “Company”) entered into an executive employment agreement (the “Agreement”) with Brian Hungerford pursuant to which Mr. Hungerford will be employed by the Company as Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Hungerford was appointed as Chief Financial Officer at Kiromic Biopharma, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On October 1, 2023, Kiromic Biopharma, Inc. (the “Company”) entered into an executive employment agreement (the “Agreement”) with Brian Hungerford pursuant to which Mr. Hungerford will be employed by the Company as Chief Financial Officer.

View on SEC.gov

Source: SEC EDGAR

accession 0001558370-23-016208

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.